Cited 0 times in Scipus Cited Count

Ahmed Valve Implant Surgery with Adjunctive Mitomycin C and Selective 5-Fluorouracil Injection

Other Title
마이토마이신과 선택적인 5-Fluorouracil 주사치료를 병용한 아메드밸브 삽입술
Authors
Yun, IS  | Lee, JD | Kim, YH | Ahn, JH
Citation
Journal of the Korean ophthalmological society, 57(3). : 468-476, 2016
Journal Title
Journal of the Korean ophthalmological society
ISSN
0378-64712092-9374
Abstract
PURPOSE: To evaluate the surgical results of Ahmed valve implant surgery with adjunctive mitomycin C and selective postoperative 5-fluorouracil (5-FU) subconjunctival injection with a needling procedure.
METHODS: In this retrospective study, 40 eyes of 40 patients who had undergone Ahmed valve implant surgery with adjunctive mitomycin C were observed for at least 1 year. The Ahmed valve was implanted after 5-minute application of 0.04% mitomycin C. Selective 5-FU injection with a needling procedure was performed during the follow- up period based on intraocular pressure (IOP). Hypertensive phase was defined as IOP higher than 21 mm Hg within 3 months after operation. IOP higher than 18 mm Hg regardless of IOP-lowering medications at 2 consecutive visits was considered to be a surgical failure.
RESULTS: The mean follow-up period was 35.5 ± 12.4 months. Preoperative intraocular pressure was 32.8 ± 7.5 mm Hg, which decreased to 14.0 ± 4.2 mm Hg post-operatively. The number of glaucoma medications decreased significantly from 3.8 ± 0.5 to 2.0 ± 1.0. Eleven of 40 eyes (27.5%) experienced hypertensive phase at 6.0 ± 3.1 weeks after surgery. Kaplan-Meier survival analysis showed cumulative probability of surgical success rates of 82.5%, 79.6%, 72.7%, and 58.8% at 1, 2, 3, and 4 postoperative years respectively. There were no risk factors that affecting surgical failure except age (hazard ratio = 0.17, p = 0.02).
CONCLUSIONS: Ahmed valve implant surgery with adjunctive mitomycin C and selective 5-FU injection with a needling procedure showed good success in refractory glaucoma.

목적: 난치성 녹내장의 치료로 mitomycin C (MMC)를 병용한 Ahmed 밸브 삽입술 후 선택적인 5-fluorouracil (5-FU) 결막하주사와 needling을 받은 환자들의 수술 결과를 평가해 보고자 한다.
대상과 방법: Ahmed 밸브 삽입술 후 최소 1년 이상 관찰이 가능했던 40명 40안을 대상으로 후향적 의무기록 분석을 통한 연구를 진행하였다. MMC 0.04%를 5분간 접촉 후 씻어내고 Ahmed 밸브를 삽입한 후 경과관찰하면서 선택적으로 추가적인 5-FU 결막하주사 및 needling revision을 병행하였다. 술 후 3개월 이내 안압이 22 mmHg 이상 상승한 경우를 고안압기로 정의하였고 이후 약제사용 여부에 관계없이 18 mmHg보다 높은 안압이 연속하여 2회 이상 측정될 때를 수술 실패로 정의하였다.
결과: 평균 추적관찰 기간은 35.5 ± 12.4개월이었다. 안압은 술 전 32.8 ± 7.5 mmHg에서 술 후 14.0 ± 4.2 mmHg, 녹내장 약물은 3.8 ± 0.5개에서 2.0 ± 1.0개로 감소하였다. 11안(27.5%)에서 고안압기를 경험하였으며 평균발생 기간은 6.0 ± 3.1주였다. Kaplan-Meier 생존분석 결과 녹내장 수술 후 1년, 2년, 3년, 4년 누적성공률은 각각 82.5%, 79.6%, 72.7%, 58.8%였다. 수술 실패의 예측인자는 연령(hazard ratio=0.17, p=0.02) 이외에 다른 연관된 인자는 없었다.
결론: 난치성 녹내장에서 술 중 MMC를 병용한 Ahmed 밸브 삽입술은 술 후 선택적인 5-FU needling을 시행하였을 때 좋은 성공률을 보였다.
Keywords

DOI
10.3341/jkos.2016.57.3.468
Appears in Collections:
Journal Papers > School of Medicine / Graduate School of Medicine > Ophthalmology
Ajou Authors
안, 재홍  |  윤, 일석
Files in This Item:
There are no files associated with this item.
Export

qrcode

해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse